EXPECTATIONS, VALUE AND TIMING
A short list of instrument-specific cases: what changed, what the price assumes, what could go wrong and what we need to see next.
These briefs organise research. They do not establish a reviewed investment window or an instruction to trade. Prices are dated observations.
THE WORKING SHORTLIST
Open a brief for its sources, assumptions, countercase and conditions that would strengthen or invalidate the view.
Research brief · waiting for evidence
MSFT · Nasdaq
Cloud growth is established. The present research question is whether incremental AI investment can produce sufficient shareholder cash at the valuation already paid.
Recorded quote: USD 521.08 · 22 Oct 2026, 20:00 UTC
Read the evidence and conditionsResearch brief · waiting for evidence
AAPL · Nasdaq
A premium foldable launch creates a testable commercial hypothesis, but the dated share price already represents about 39.9 times an issuer-derived trailing EPS bridge. Scarcity and launch enthusiasm still need to become durable customer value and shareholder economics.
Recorded quote: USD 348.22 · 22 Oct 2026, 20:00 UTC
Read the evidence and conditionsResearch brief · waiting for evidence
NFLX · Nasdaq
A mature cash-generating platform now needs evidence that its advertising setback is temporary. A lower share price alone does not establish an entry.
Recorded quote: USD 67.05 · 22 Oct 2026, 20:00 UTC
Read the evidence and conditionsEach material revision keeps its original assessment, evidence dates and conditions. A missed review or old quote remains visible. Later outcomes can challenge the earlier view without rewriting what was knowable then.
Inspect research quality ↗ Follow the wider research changes ↗